The value of genetic thrombophilia testing in elderly patients with an unprovoked venous thromboembolism is unclear. We assessed whether the Factor V Leiden and the prothrombin G20210A mutation are associated with recurrent venous thromboembolism in elderly patients in a prospective multicenter cohort study
Factor V Leiden is the most common genetic defect associated with venous thromboembolism. Its clinic...
Background-Homozygous or double heterozygous factor V Leiden and/or prothrombin G20210A is a rare in...
Background-Homozygous or double heterozygous factor V Leiden and/or prothrombin G20210A is a rare in...
The value of genetic thrombophilia testing in elderly patients with an unprovoked venous thromboembo...
The value of genetic thrombophilia testing in elderly patients with an unprovoked venous thromboembo...
BACKGROUND The value of genetic thrombophilia testing in elderly patients with an unprovoked veno...
AbstractOBJECTIVESThe study was done to determine whether the G20210A mutation in the prothrombin ge...
Background A recently discovered mutation in coagulation factor V (Arg 506 \u2192 Gln, referred to a...
Individuals with factor V Leiden or prothrombin G20210A mutations are at a higher risk to develop ve...
The presence of the 20210A allele of the prothrombin gene has recently been shown to be a risk facto...
Objective: In the present study, we aimed to consider the relation between the manifestations of ven...
Individuals with factor V Leiden or prothrombin G20210A mutations are at a higher risk to develop ve...
Background-Homozygous or double heterozygous factor V Leiden and/or prothrombin G20210A is a rare in...
Background-Homozygous or double heterozygous factor V Leiden and/or prothrombin G20210A is a rare in...
Factor V Leiden is the most common genetic defect associated with venous thromboembolism. Its clinic...
Factor V Leiden is the most common genetic defect associated with venous thromboembolism. Its clinic...
Background-Homozygous or double heterozygous factor V Leiden and/or prothrombin G20210A is a rare in...
Background-Homozygous or double heterozygous factor V Leiden and/or prothrombin G20210A is a rare in...
The value of genetic thrombophilia testing in elderly patients with an unprovoked venous thromboembo...
The value of genetic thrombophilia testing in elderly patients with an unprovoked venous thromboembo...
BACKGROUND The value of genetic thrombophilia testing in elderly patients with an unprovoked veno...
AbstractOBJECTIVESThe study was done to determine whether the G20210A mutation in the prothrombin ge...
Background A recently discovered mutation in coagulation factor V (Arg 506 \u2192 Gln, referred to a...
Individuals with factor V Leiden or prothrombin G20210A mutations are at a higher risk to develop ve...
The presence of the 20210A allele of the prothrombin gene has recently been shown to be a risk facto...
Objective: In the present study, we aimed to consider the relation between the manifestations of ven...
Individuals with factor V Leiden or prothrombin G20210A mutations are at a higher risk to develop ve...
Background-Homozygous or double heterozygous factor V Leiden and/or prothrombin G20210A is a rare in...
Background-Homozygous or double heterozygous factor V Leiden and/or prothrombin G20210A is a rare in...
Factor V Leiden is the most common genetic defect associated with venous thromboembolism. Its clinic...
Factor V Leiden is the most common genetic defect associated with venous thromboembolism. Its clinic...
Background-Homozygous or double heterozygous factor V Leiden and/or prothrombin G20210A is a rare in...
Background-Homozygous or double heterozygous factor V Leiden and/or prothrombin G20210A is a rare in...